Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke
Abstract Background Studies have suggested that glycoprotein IIb/IIIa antagonists such as tirofiban are beneficial for patients with acute coronary syndromes. However, it is still uncertain about the efficacy and safety of tirofiban in patients with acute ischemic stroke (AIS). Methods In this prosp...
Main Authors: | Chunrong Tao, Yuyou Zhu, Chao Zhang, Jianlong Song, Tianlong Liu, Xiaodong Yuan, Wenwu Luo, Changchun Chen, Dezhi Liu, Yuanyuan Zhu, Jie Liu, Wei Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-021-02268-8 |
Similar Items
-
SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
by: Yan-Jun Zhang, et al.
Published: (2014-04-01) -
Progressive ischemic stroke: Clinical features and evaluation of short- and long-term tirofiban therapy
by: Turgay Demir, et al.
Published: (2016-12-01) -
Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology
by: Chao Sun, et al.
Published: (2019-10-01) -
Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke
by: Yang Zhang, et al. -
Can Tirofiban Improve the Outcome of Patients With Acute Ischemic Stroke: A Propensity Score Matching Analysis
by: Lingxin Cai, et al.
Published: (2021-09-01)